Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil + Radiotherapy and Temozolomide in Advanced Glioblastoma
NCT07605364Phase 3Not yet recruiting
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2026
- Primary completion
- Sep 2029
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mycophenolate mofetil in glioblastoma (GBM), sponsored by Cancer and Leukemia Group B. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
mycophenolate mofetil
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT07605364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07605364.